Federal Court Halts Texas Rule Allowing Access to Out-of-State Abortion Pills
The 5th U.S. Circuit Court of Appeals issued a ruling on Friday that effectively blocks a 2023 regulation from the Federal Drug Administration permitting the mailing of mifepristone to patients. This regulation had been utilized as a workaround to Texas’ stringent abortion laws. This 2023 regulation enabled healthcare providers to prescribe mifepristone remotely, allowing patients—including…
